0NIR.LSE SARTORIUS AG SARTORIUS PREF SHS
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- 0.21%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2023.
Is 0NIR.LSE undervalued?
Graham numberThe Graham number of SARTORIUS AG SARTORIUS PREF SHS cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
SARTORIUS AG SARTORIUS PREF SHS fundamental analysis
No fundamental analysis for SARTORIUS AG SARTORIUS PREF SHS yet.
SARTORIUS AG SARTORIUS PREF SHS stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About SARTORIUS AG SARTORIUS PREF SHS
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supp…
Full company profileSARTORIUS AG SARTORIUS PREF SHS financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
SARTORIUS AG SARTORIUS PREF SHS annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1.30B | 1.40B | 1.57B | 1.83B | 2.34B | - | - | - |
| Gross Profit | 632M | 707M | 804M | 941M | 1.21B | - | - | - |
| Operating Income | 220M | 219M | 299M | 335M | 456M | - | - | - |
| Net Income | 103M | 115M | 141M | 157M | 226M | - | - | - |
| Balance Sheet | ||||||||
| Total Assets | 1.75B | 2.30B | 2.53B | 2.87B | 4.70B | - | - | - |
| Total Liabilities | 1.17B | 1.68B | 1.79B | 2.06B | 3.65B | - | - | - |
| Shareholders' Equity | 580M | 618M | 741M | 810M | 1.05B | - | - | - |
| Cash & Short-term Investments | 72.1M | 74.7M | 67.3M | 66.9M | 218M | - | - | - |
| Total Debt | 515M | 932M | 895M | 881M | 1.89B | - | - | - |
| Cash Flow | ||||||||
| Operating Cash Flow | 170M | 207M | 245M | 377M | 512M | 873M | 734M | - |
| Capital Expenditure | 149M | 197M | 233M | 226M | 240M | 407M | 523M | 0.00 |
| Ratios | ||||||||
| ROE | 17.8% | 18.6% | 19.1% | 19.3% | 21.6% | - | - | - |
| ROA | 5.9% | 5.0% | 5.6% | 5.5% | 4.8% | - | - | - |
| Net Profit Margin | 7.9% | 8.2% | 9.0% | 8.6% | 9.7% | - | - | - |
| Debt to Equity | 0.89x | 1.51x | 1.21x | 1.09x | 1.81x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
SARTORIUS AG SARTORIUS PREF SHS dividends
SARTORIUS AG SARTORIUS PREF SHS has not paid dividends in the last 9 fiscal years.
Last stock split: 4:1 on Jun 13, 2016.
Who owns SARTORIUS AG SARTORIUS PREF SHS
- Insiders 25.61%
- Institutions 30.47%
- Public & others 43.92%
- Free float 27.5M
SARTORIUS AG SARTORIUS PREF SHS company profile
- Company name
- SARTORIUS AG SARTORIUS PREF SHS
- Ticker
- 0NIR.LSE
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Commercial Services & Supplies
- Employees
- 14,273
- Fiscal year end
- December
- Address
- Otto-Brenner-Strasse 20, Göttingen, Germany, 37079
- Phone
- 49 551 308 0
- Website
- sartorius.com
About SARTORIUS AG SARTORIUS PREF SHS
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
SARTORIUS AG SARTORIUS PREF SHS management
9- Dr. Michael GrosseCEO & Chairman of the Executive Board · born 1967
- Dr. Florian Funck Dipl.Kfm.CFO & Member of Executive Board · born 1971
- Dr. Rene FaberHead of Bioprocess Solutions Division & Member of Executive Board · born 1975
- Dr. Alexandra GatzemeyerHead of the Lab Products & Services Division and Member of Executive Board · born 1979
- Ms. Patricia SpannagelHead of Quality Assurance - Mechatronics Division Goettingen
- Ralf MohrschladtPhysicist & Head of Supply Chain Management - Germany
- Ms. Petra MullerHead of Investor Relations
- Mr. Maurice PhelanPresident of Sartorius North America
- Dr. Theo ThijssenPresident of Environmental Technology Division